Gehirnautopsie zeigt, dass Alzheimer-Medikament nur einige Gehirnregionen reinigt
https://www.sciencealert.com/rare-brain-autopsy-hints-at-why-alzheimers-drugs-are-failing
Gehirnautopsie zeigt, dass Alzheimer-Medikament nur einige Gehirnregionen reinigt
https://www.sciencealert.com/rare-brain-autopsy-hints-at-why-alzheimers-drugs-are-failing
7 Kommentare
Some is better than none
Exercise and sleep is more effective.
>For the AD portrait, the top three scoring treatments for reversing AD expression with little effect on exacerbating AD expression were for exercise.
[https://www.nature.com/articles/s41598-022-22179-z#Sec2](https://www.nature.com/articles/s41598-022-22179-z#Sec2)
It says “a rare brain autopsy.” Why are these rare? How about if you want to take this cutting edge drug you need to agree to a brain autopsy? How about a 2 tier cost structure? One price for agreed autopsy, full price for no autopsy.
It’s weird they’re still wasting time on the plaques, it seems like that is the effect rather than the cause
I’m okay with partial benefit.
I really thought we established that Aduhelm was a bust a few years ago. I’m betting the stakeholders are appreciative of the postmortem to try to recoup some of the costs, but like… it’s been established for a long time now that it really wasn’t efficacious, no? I know Biogen isn’t admitting the flop, but the pharma population as a whole has known for no less than a couple years now
A newer hypothesis is that alzheimer is a result of several reinforcing processes. Viral activity in the brain, blood-brain permeability, plaques, decreasing activity of the glymphatic system etc. They are all a cause, but also an effect. Once the vicious cycle has started, treating only one issue is not enough.
So anti-plaque drugs could be a key part of a working treatment, but we need a way to treat all other issues at the same time.